Showing results (471-480 of 654) with videos related to
Sort By:
Pageof 66
Urology|April 1, 1997
Planning controlled clinical trials. Prostatic cancerL Denis, B J Norlén, L Holmberg, et al.Molecular and Cellular Biology|January 16, 1999
A complex containing RNA polymerase II, Paf1p, Cdc73p, Hpr1p, and Ccr4p plays a role in protein kinase C signalingM Chang, D French-Cornay, H Y Fan, et al.Molecular and Cellular Biology|July 11, 2007
PAB1 self-association precludes its binding to poly(A), thereby accelerating CCR4 deadenylation in vivoGang Yao, Yueh-Chin Chiang, Chongxu Zhang, et al.Cell|March 10, 2001
The transcription factor associated Ccr4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiaeM Tucker, M A Valencia-Sanchez, R R Staples, et al.Proteins|November 16, 2017
Defining the protein complexome of translation termination factor eRF1: Identification of four novel eRF1-containing complexes that range from 20S to 57S in sizeClyde L Denis, Roy Richardson, Shiwha Park, et al.Fertility and Sterility|June 1, 1997
Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization patientsA L Denis, M Guido, R D Adler, et al.Molecular and Cellular Biology|September 22, 1999
The CCR4 and CAF1 proteins of the CCR4-NOT complex are physically and functionally separated from NOT2, NOT4, and NOT5Y Bai, C Salvadore, Y C Chiang, et al.The Prostate|January 1, 1994
Phase I trial of high-dose fosfestrol in hormone-refractory adenocarcinoma of the prostateJ P Droz, E De Smedt, J Kattan, et al.Journal of Molecular Biology|May 4, 2010
PUF3 acceleration of deadenylation in vivo can operate independently of CCR4 activity, possibly involving effects on the PAB1-mRNP structureDarren Lee, Takbum Ohn, Yueh-Chin Chiang, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 1988
The early results from a randomised study of radiotherapy versus Nolvadex (tamoxifen) as initial treatment for stage III breast cancerM R Williams, D Gilson, L Marsh, et al.Pageof 66